Big Data in Precision Medicine
With ESMO 2016 coming to a close in Copenhagen, MDCPartners is getting ready for their next stop: we are this year’s Innovation Partner of the Big Data in Precision Medicine meeting, which will take place in the Capital Hilton in Washington, D.C. on November 1-2, 2016.
This meeting attracts 250-300 senior executives from across the drug development sector including Big Pharma, biotech, leading solution providers, government, healthcare and academia. The meeting addresses the opportunities and challenges of big and real-world data, and how machine learning and cognitive computing can be applied in the context of drug development. View the meeting’s streams and the meeting agenda here.
Private Clinical Trial Data in the Real-World Data Context
On Tuesday November 1 at 9:30 AM, MDCPartners’ Chief Scientific Officer David Cocker will present our findings on “The value case of private pharma clinical trial data in the real-world data context”.
Real-world data (RWD) is generally the term used to refer to any data which is collected outside of randomized clinical trials (RCT). The data can be from sources including patient data from hospitals and clinicians. The premise is that RWD combined with information from RCTs can provide better research outcomes and improved healthcare.
Unfortunately, available clinical trial information data is really not that big. Often it is also dispersed and contradictory, and includes duplicates through multiple entries that are not verified and/or matched. Many transformative actions with data are frequently heralded as a big data panacea long before any analytical conclusion can be applied.
This presentation will explore the challenges faced when approaching the question of clinical trial data merging and its interoperability with public clinical trial data for creating valuable insights for study placement.
ta-Scan’s data team will be present in Washington, D.C. as well to show the precision medicine experts how our clinical business intelligence software ta-Scan can leverage today’s medical big data challenges.
If you want to learn more about our software solutions, you can meet us personally during the exhibition at booth #1 or make an appointment with CSO David Cocker or Strategic Data Analyst, Oncology Jonathan Crowther.